Qianjiang Yongan Pharmaceutical Co.,Ltd. Fundamental Rankings

This page is comprehensive fundamental data for Qianjiang Yongan Pharmaceutical Co.,Ltd.. Fundamentals are ordered by how Qianjiang Yongan Pharmaceutical Co.,Ltd. ranks compared to other companies (ordered high to low). All money values are in CNY. All data is powered by Quandl.

Cite in Wikipedia:

Indicator Value n/price Rank Date Historic
Other current assets267,847,8710.09811552015-06-30historic
Interest receivable4,341,6630.00159692015-06-30historic
Proceeds from sell of investment279,000,0000.10219742015-06-30historic
Construction materials4,536,0450.00166792015-06-30historic
Cash from minority shareholders of subsidiaries4,500,0000.00165822015-06-30historic
Special reserve2,449,5259.0E-41622015-06-30historic
Capital reserve604,566,5230.221441912015-06-30historic
Net cash flows from investing activities-1,320,129-4.8E-42692015-06-30historic
Fixed assets596,323,4230.218422922015-06-30historic
Disposal of fixed assets and others236,9519.0E-53082015-06-30historic
Intangible assets84,765,3300.031053472015-06-30historic
Diluted eps00.03962015-06-30historic
Refunds of taxes2,108,2687.7E-44192015-06-30historic
Net change in cash25,993,7850.009524322015-06-30historic
Total non-current assets701,876,6600.257084922015-06-30historic
Selling expenses17,868,5150.006545232015-06-30historic
Purchases of fixed assets and others23,084,4950.008465722015-06-30historic
Other receivables13,943,3450.005115912015-06-30historic
Payroll payable6,923,7900.002545922015-06-30historic
Total cost of goods sold295,710,2960.108316492015-06-30historic
Cash inflows from operating activities318,715,3910.116746682015-06-30historic
Prepayment20,253,1980.007426742015-06-30historic
Revenue301,075,6850.110286812015-06-30historic
Cash outflows from operating activities295,900,3500.108386852015-06-30historic
Net cashflow from financing activities4,500,0000.001656862015-06-30historic
Non-operating loss191,6977.0E-56912015-06-30historic
Total liabilities and equity1,196,908,5170.43847112015-06-30historic
Cash paid for taxes18,078,9790.006627322015-06-30historic
Deferred tax assets4,627,3210.001697392015-06-30historic
Comprehensive income attributable to minority shareholders-242,691-9.0E-58122015-06-30historic
Minority interests gain-242,691-9.0E-58252015-06-30historic
Operating profit12,565,7490.00468582015-06-30historic
Net income12,057,9400.004428612015-06-30historic
Minority interest4,257,3090.001568612015-06-30historic
Total comprehensive income12,026,8140.004418632015-06-30historic
Total profit15,330,2090.005628662015-06-30historic
Notes receivable497,9001.8E-410072015-06-30historic
Inventories53,366,7930.0195510202015-06-30historic
Accounts payable31,785,7870.0116410302015-06-30historic
Net cash and cash equivalents ending balance56,619,2210.0207410932015-06-30historic
Cash inflows from financing activities4,500,0000.0016511462015-06-30historic
Financial expenses-1,991,589-7.3E-412102015-06-30historic
Total liabilities83,468,7460.0305712182015-06-30historic
Other payables1,196,9134.4E-412422015-06-30historic